Prostate Cancer, Incontinence, Metabolic Disease
Conditions
Brief summary
The Continence, Sexual and Metabolic Health (CONTROL 4 LIFE) study will evaluate the recovery of continence, sexual function, and health outcomes in individuals who have undergone surgery for prostate cancer. The purpose of this study is to better understand the timelines of recovery for these outcomes after surgery for prostate cancer. As part of this study, all participants will receive resources offered by Alberta Health Services regarding pre- and post-prostatectomy care, including information on pelvic floor exercises. Through the CONTROL 4 LIFE study, the investigators will also be evaluating outcomes related to physical activity, fitness and quality of life. These assessments will enable the investigators to better understand how well and how long it takes for individuals to recover after surgery for prostate cancer.
Detailed description
The investigators aim to conduct a trial examining the feasibility and the effects of a combined pelvic health rehabilitation and exercise program that can be delivered both in-person and virtually in individuals who have been treated with prostatectomy for prostate cancer. This hybrid format will support equitable program delivery regardless of location of residence. To address issues faced by men with prostate cancer, the investigators propose an intervention (offered virtually and in-person) that includes: 1) online education to support continence, sexual and overall health; 2) a group exercise fitness program that considers the needs and restrictions specific to the early post-prostatectomy surgical period, and 3) functional and intensive pelvic floor muscle exercise retraining to promote continence and sexual recovery. Main objectives of this study 1. Determine the feasibility, defined as the acceptability and appropriateness, of a combined pelvic health rehabilitation and exercise fitness program that can be delivered both in-person and virtually. 2. Determine the effects of the program on the primary outcome measure of urinary continence in comparison with usual care. Secondary objectives of this study 1. To determine the effects of the program on cardiometabolic indicators in comparison with usual care. 2. To determine the effects of the program on general fitness, secondary outcomes of urinary continence, sexual function, self-efficacy, and cancer symptom burden, in comparison with usual care.
Interventions
BEHAVIORALPelvic floor exercise program
General exercises will be prescribed along with a specialized pelvic floor program
BEHAVIORALGeneral exercise
A general progressive resistance exercise program
BEHAVIORALPhysical Activity Counseling
Advice on increasing physical activity
Sponsors
University of Alberta
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
DOUBLE (Subject, Outcomes Assessor)
Masking description
The participants will be randomized after the baseline assessment and will have the option to take part in an additional exercise intervention component.
Intervention model description
Zelen design with randomization
Eligibility
Sex/Gender
MALE
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* have a diagnosis of prostate cancer (stage I to IV); * be scheduled for a prostatectomy surgery (any surgical approach); * have no restriction to participate in at least mild levels of physical activity, as confirmed by the Physical Activity Readiness Questionnaire (PAR-Q+); * speak and understand English. * adult: 18 years of age or older * optional exercise component: willing and able to commit to the 12-week intervention
Exclusion criteria
* have any medical conditions that may interfere with continence (i.e. neurological diseases); * have any contraindications to exercise testing or training; * have recent (\>6 months) modifications to any medication aiming to reduce urinary incontinence (i.e. Myrbetric); * do not have regular access to the internet and a smart device or a computer at home/ at their community center; * are already receiving a pelvic floor exercise program through a pelvic floor physical therapist from their community.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Completion Rate | Final assessment at one year | The number of participants completing the study including all planned outcomes |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Recruitment rate | One year | Percentage of participants who are eligible and agree to participate |
| Adherence rate | Post-intervention: 12 weeks | Adherence to the intervention components |
| 24-hour pad test | 24 hours at two time points: immediate post surgery and 12 weeks | Mean: Individual's urine loss by measuring weight (grams) of an absorbent pad |
| Expanded Prostate Cancer Index Composite for Clinical Practice | One-year | 16-questions: urinary function, sexual and erectile function, bowel and hormonal function; Scores: 0 (no symptoms) to 60 (most severe symptoms); Higher scores indicate worse functioning |
| International Consultation on Incontinence Questionnaire | One-year | 13 questions: occurrence and bother of lower urinary tract symptoms, quality of life; Range of scores: 0-20 voiding subscale; 0-20 incontinence symptoms; Higher scores indicate worse functioning |
| 36-Item Short Form Survey | One-year | Quality of life measure: Items are scored 0-100 (percentage of total possible score): Higher scores equal better quality of life |
| Edmonton Symptom Assessment Scale | One year | 11-item ordinal scale; Range 0-60; with higher scores indicating higher symptom burden |
| Self-efficacy Questionnaire: Incontinence | One year | 6 item ordinal scale: Range 0-60; Higher scores indicating higher self-efficacy |
| Grip Strength | 12 weeks | Dyanometer: mean in kgs |
| Lower body strength | 12-weeks | Sit-to-stand: mean number completed in 30 seconds |
| Upper limb mobility | 12 weeks | Shoulder Range of Motion: mean value in degrees |
| Flexibility | 12-weeks | Sit and reach: mean value in cm |
| Balance | 12-weeks | One-leg stance test: mean time in seconds |
| Walking endurance | 12-weeks | Six-minute walk test: mean distance in metres |
| Body Mass Index | 12-weeks | Height and weight will be combined to calculate BMI: mean: weight in kilograms divided by height in metres squared |
| Glucose | 12-weeks | mmol/L (mean value) |
| Insulin level | 12-weeks | mmol/L (mean value) |
| Lipid profile | 12-weeks | Cholesterol level: mg/dL (mean value) |
| Hemoglobin A1c | 12-weeks | Value in percentage (mean value) |
Countries
Canada
Contacts
CONTACTMargaret L McNeely
CONTACTChris Sellar
PRINCIPAL_INVESTIGATORNathan Hoy, MD
University of Alberta
PRINCIPAL_INVESTIGATORHoward Evans, MD
University of Alberta
PRINCIPAL_INVESTIGATORMargaret McNeely
University of Alberta
Outcome results
None listed